TickerFacts.

Genprex, Inc. (GNPX): Total Liabilities

Annual figures by period end, from SEC filings.

$2.20M
As of 2025-12-31
$2.34M
As of 2026-06-30
$2.50M2021-12-31: $1.59M2022-06-30: $2.15M2022-09-30: $2.46M2024-12-31: $2.50M2025-12-31: $2.20M$2.20M
2021-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$2.20M-12.3%2026-03-30, Balance as of period end
2024-12-31$2.50Mn/a2026-03-30, Balance as of period end
No annual figure between 2022-09-30 and 2024-12-31.
2022-09-30$2.46Mn/a2023-03-31, Balance as of period end
2022-06-30$2.15Mn/a2023-03-31, Balance as of period end
2021-12-31$1.59Mn/a2023-03-31, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Genprex, Inc. (GNPX)2025-12-31$2.20M-12.3%
Oragenics Inc (OGEN)2025-12-31$1.79M+6.1%
Medicus Pharma Ltd. (MDCX)2025-12-31$10.02M+299.0%
Longeveron Inc. (LGVN)2025-12-31$4.59M+24.9%
Lunai Bioworks Inc. (LNAI)2026-06-30$18.97M-35.9%
Nanoviricides, Inc. (NNVC)2026-06-30$1.20M-7.7%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$8.22M+357.5%
Traws Pharma, Inc. (TRAW)2025-12-31$11.25M-80.1%
Cocrystal Pharma, Inc. (COCP)2025-12-31$3.38M-14.0%

Compare GNPX, OGEN, MDCX, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗